CN Patent

CN113144218A — 包含美洛昔康的药物组合物

Assigned to Axsome Therapeutics Inc · Expires 2021-07-23 · 5y expired

What this patent protects

本发明涉及包含美洛昔康的药物组合物。本发明公开了包含NSAID的组合物，例如与环糊精和/或碳酸盐或碳酸氢盐组合的美洛昔康。这些组合物可以口服施用，例如改善NSAID用于治疗诸如疼痛的病症的生物利用度或药代动力学。

USPTO Abstract

本发明涉及包含美洛昔康的药物组合物。本发明公开了包含NSAID的组合物，例如与环糊精和/或碳酸盐或碳酸氢盐组合的美洛昔康。这些组合物可以口服施用，例如改善NSAID用于治疗诸如疼痛的病症的生物利用度或药代动力学。

Drugs covered by this patent

Patent Metadata

Patent number
CN113144218A
Jurisdiction
CN
Classification
—
Expires
2021-07-23
Drug substance claim
No
Drug product claim
No
Assignee
Axsome Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.